COPLA® is a biodegradable implant for cartilage repair. It is designed to enable healing of the cartilage tissue to avoid further degeneration of the joint. COPLA® is intended for the surgical treatment of cartilage and bone-cartilage lesions in the knee joint of adult patients.
COPLA® is an investigational device and is not yet approved for commercial use in any country. The described design properties and intended purpose are subject to further validation.
The joint surface is composed of cartilage and underlying bone. The cartilage over the bone functions as a cushioning and lubricating surface and its health is essential for our ability to move pain-free.
Unlike bone, cartilage has very limited self-healing capacity due to the absence of blood vessels and a low number of cells. If a damaged joint surface is left untreated, the problem can escalate into further joint degeneration and osteoarthritis, which is a chronic degenerative joint disease affecting the whole joint as an organ.
Therefore, it is essential to treat cartilage lesions in a timely and efficient manner.
COPLA® is made of materials that have been in clinical use in implantable medical devices safely for decades.
COPLA® is an investigational device and is not yet approved for commercial use in any country. The described design properties and intended purpose are subject to further validation.
Our in-house production utilizes our patented technology to manufacture COPLA® implants of the highest quality and standards. To ensure the production of high-quality products, we have implemented our own cleanroom facilities in Tampere, Finland.
